| Breakdown | TTM | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.14B | 39.08B | 34.47B | 31.12B | 29.00B | 28.48B |
| Gross Profit | 7.56B | 6.58B | 4.50B | 753.00M | 3.34B | 3.42B |
| EBITDA | 5.07B | 4.20B | 3.67B | -1.58B | 1.18B | 1.12B |
| Net Income | 2.23B | 1.41B | 1.18B | -4.53B | -467.00M | -453.00M |
Balance Sheet | ||||||
| Total Assets | 61.86B | 56.64B | 50.87B | 47.91B | 51.17B | 44.14B |
| Cash, Cash Equivalents and Short-Term Investments | 13.11B | 10.19B | 7.25B | 4.59B | 8.52B | 5.92B |
| Total Debt | 3.73B | 3.96B | 3.77B | 4.78B | 3.22B | 2.73B |
| Total Liabilities | 50.74B | 45.96B | 41.51B | 39.12B | 33.99B | 28.92B |
| Stockholders Equity | 10.75B | 10.30B | 9.07B | 8.50B | 17.19B | 14.96B |
Cash Flow | ||||||
| Free Cash Flow | 5.92B | 4.10B | 1.38B | 394.00M | 1.06B | 959.00M |
| Operating Cash Flow | 7.77B | 5.82B | 2.89B | 1.62B | 2.22B | 1.95B |
| Investing Cash Flow | -1.95B | -1.62B | 1.25B | -1.63B | -1.12B | -958.00M |
| Financing Cash Flow | -3.03B | -1.14B | -2.26B | -1.13B | -568.00M | -340.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | €209.24B | 27.32 | 12.22% | 2.18% | 2.41% | -20.54% | |
67 Neutral | €143.91B | 65.26 | 20.99% | ― | 7.21% | 852.54% | |
66 Neutral | €1.51B | 17.79 | 6.02% | 2.03% | 12.81% | 122.97% | |
66 Neutral | €1.52B | 55.16 | 16.47% | 2.76% | 2.34% | 19.31% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | €11.30B | 33.51 | 27.32% | ― | 7.63% | 973.99% | |
57 Neutral | €1.36B | -32.76 | -3.44% | 3.12% | -2.35% | 89.53% |